Creating functional human tissues on demand via 3D bio-printing and tissue engineering.
Currently Operating in Nine Regions
Press Mentions
June 5, 2019
Aspect Biosystems Partners with Merck, GSK, and McGill University to Enable Development of Immuno-Oncology Therapeutics
This $2.2M project is made possible by contributions from CQDM, CCS, Merck, GSK, Aspect Biosystems, and McGill University.
Read more »November 29, 2023
Aspect Biosystems Named to Fast Company's 2023 List of the Next Big Things in Tech
Aspect Biosystems, a biotech company specializing in 3D bioprinting, has been recognized by Fast Company as one of the world's most innovative companies for its advancements in creating functional...
Read on Yahoo Finance »October 18, 2023
Treating incurable diseases with bioprinted tissue: Aspect Biosystems
Aspect Biosystems is using 3D bioprinting technology to create human tissues for medical research and potential treatment of incurable diseases. The company aims to revolutionize the field of...
Read on BNN »November 15, 2022
Tamer Mohamed, CEO of Aspect Biosystems, is turning sci-fi into reality
Bloomberg New Economy Catalyst celebrates the world’s brightest thinkers and innovators who are accelerating solutions at the leading edge of technology and policy. These are the innovations making...
Read on YouTube »August 3, 2022
Bloomberg New Economy Announces 2022 Class of Catalysts
The 28 people moving the world toward a more equitable, sustainable future.
Read on Bloomberg.com »July 21, 2020
The B.C. engineer behind 3D-printed human tissues
Competitive spirit has driven engineer-turned-entrepreneur Tamer Mohamed’s success with Aspect Biosystems
Read on Business in Vancouver »Work at Aspect Biosystems
Posted May 15, 2024
Vice President, Process Development & Manufacturing
Vancouver, BC, Canada
View Listing »More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on Aspect Biosystems and over 396 other ventures working to solve the world's toughest problems.